The 4th Annual RAS Targeted Drug Development Summit is dedicated to the Therapeutic Landscape of Druggable RAS-Mutant Cancers.
The 4th Annual RAS Targeted Drug Development Summit covers topics such as:
- Patient Selection & Stratification in RAS Targeted Therapeutics Clinical Trials
- Design Principles of Covalent Fragment Libraries
- Intrinsic & Adaptive Resistance
- Reviewing Targeted Therapies Against GI Cancers – What is Next?
- Enhancing Tissue Specificity & Understanding PK/PD Relationships in Pre-Clinical Settings
- A Novel Arenaviral Immunotherapy for Targeting Multiple Mutated KRAS Epitopes
